RecruitingNot ApplicableNCT04900688

Prospective Evaluation of the LithoVue Elite Ureteroscope

First Clinical Evaluation of the New Flexible Disposable Ureteroscope (LithoVue Elite): A Multicenter Single-arm Prospective Trial

Sponsor

Centre hospitalier de l'Université de Montréal (CHUM)

Enrollment

150 participants

Start Date

Jan 16, 2023

Study Type

INTERVENTIONAL

Conditions

Kidney Stone

Summary

Flexible ureteroscopy has become the main surgical treatment for kidney stone disease. The procedure uses many types of ureteroscopes (disposable and non-disposable). Currently we are using the LithoVue Single-Use Digital Flexible Ureteroscope. The Health Canada approved LithoVue Elite disposable flexible ureteroscope will now offer novel pressure sensory capacity. In order to evaluate the new ureteroscopy we will be conducting a prospective multi-institution study in order to determine the main features, capacity and abilities of the new scope. We will evaluate the impact of intra renal pressure on pain, quality of life and possible infectious complications.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

Patient scheduled for ureteroscopy and laser lithotripsy
Non-obstructing renal stone 2 cm total stone diameter (if multiple stones, then sum of maximum diameters) or less undergoing flexible ureteroscopy
age > 18 years

Exclusion Criteria5

age < 18 years
pregnancy status =positive
indwelling nephrostomy tube
severe hydronephrosis that in the opinion of the investigator, will make it challenging to make the patient stone free
renal anomalies

Interested in this trial?

Get notified about updates and connect with the research team.